3
Plaintiffs
2
Defendants
10
Accused
Products
2
Patents-in-Suit
570
Days in
Litigation
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A method for enhancing muscle performance or recovery from fatigue wherein said method comprises administering a composition comprising a ketoacid and an amino acid wherein said amino acid is cationic or dibasic.
|
Invalid (102 and 103)
Entry 295 |
| 2 |
The method, according to claim 1, wherein said composition further comprises a compound selected from the group consisting of glutamate, glutamine, and glycine.
|
Invalid (102 and 103)
Entry 295 |
| 5 |
The method, according to claim 4, wherein said composition comprises .alpha.-ketoisocaproic acid, or a salt thereof.
|
Invalid (102 and 103)
Entry 295 |
| 7 |
The method, according to claim 6, wherein said composition comprises arginine.
|
Invalid (102 and 103)
Entry 295 |
| 8 |
The method, according to claim 1, wherein said amino acid and said ketoacid are conjugated.
|
Invalid (102 and 103)
Entry 295 |
| 9 |
The method, according to claim 1, wherein said composition is administered orally.
|
Invalid (102 and 103)
Entry 295 |
| 18 |
The method, according to claim 1, wherein said method is used on a human.
|
Invalid (102 and 103)
Entry 295 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
An isolated hydrosoluble salt of creatine of the formula: ##STR2## wherein A.sup.- represents the anion of citric, maleic, fumaric, or malic acid.
|
Valid
Entry 304 |
-
Infringement
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| CELLMASSNitrixN.O.-Xplode | US 5,973,199 A |
1
|
Infringement
Entry 304
|
| CELLMASSNitrixN.O.-Xplode | US 6,100,287 A |
1, 2, 5, 7, 8, 9, 18
|
Infringement
Entry 304
|
Medical Research Institute
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| CELLMASSNitrixN.O.-Xplode | US 5,973,199 A |
1
|
Infringement
Entry 304
|
| CELLMASSNitrixN.O.-Xplode | US 6,100,287 A |
1, 2, 5, 7, 8, 9, 18
|
Infringement
Entry 304
|